Article Details
Retrieved on: 2022-07-01 16:08:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The first patient has been dosed in a Phase II trial evaluating Treos' off-the-shelf immunotherapy PolyPEPI1018 and Roche's checkpoint inhibitor ...
Article found on: www.precisiononcologynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here